NCT07159906 2025-09-08
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
First Affiliated Hospital of Zhejiang University
Phase 1/2 Not yet recruiting
First Affiliated Hospital of Zhejiang University
Institute of Hematology & Blood Diseases Hospital, China
First Affiliated Hospital of Zhejiang University